ESMO World Congress on Gastrointestinal Cancer 2017

Oncology Meeting Resources

28 Jun - 01 Jul 2017, Barcelona, Spain

ESMO World GI 2017 square image

The ESMO World Congress on Gastrointestinal Cancer 2017 (World GI) is the premier global event in the field, encompassing malignancies affecting every component of the gastrointestinal tract and aspects related to the care of patients with gastrointestinal cancer, including screening, diagnosis and the latest management options for common and uncommon tumours.

Abstracts, presentations and webcasts are open access. The use of these presentations is for personal educational purposes only. ESMO thanks the authors for their generosity.

Watch the ESMO scientific videos

Best Abstracts Session on Colorectal Cancer, Speaker: Filippo Pietrantonio

Tips for Practice: MSI Testing in GI Cancers, Speaker: Fatima Carneiro

Prevention of Colorectal Cancer, Speaker: Nadir Arber

The Role of Microbiome in Cancer Medicine, Speaker: James Godaert

All interviews from the event on the ESMO Channel





Format available

https://oncologypro.esmo.org/Meeting-Resour...-in-the-body-when-treating-pancreatic-cancer

TTFields is an antimitotic cancer treatment that utilizes low intensity (1-3 V/cm) alternating electric fields in the intermediate frequency (100-500 kHz) delivered in two orthogonal directions using 2 pairs of transducer arrays.

Date: 28 Jun 2017
Presenter: Ofir Yesharim
Resources: Abstract
Topics: Gastrointestinal Cancers, Pancreatic Cancer

https://oncologypro.esmo.org/Meeting-Resour...astatic-pancreatic-ductal-adenocarcinoma-PDA

Hyaluronan (HA) accumulation in the tumor microenvironment is associated with aggressive malignancy and poor outcomes in solid tumors. PEGylated recombinant human hyaluronidase PH20 (PEGPH20) is an...

Date: 28 Jun 2017
Presenter: Piet Vervaet
Resources: Abstract
Topics: Gastrointestinal Cancers, Pancreatic Cancer

https://oncologypro.esmo.org/Meeting-Resour...lary-mucinous-neoplasms-IPMN-of-the-pancreas

It has been acknowledged that Intraductal papillary mucinous neoplasm (IPMN) patients have a risk of developing extrapancreatic malignancies (EPMs). However, few reports addressed the incidence which...

Date: 28 Jun 2017
Presenter: Hiroshi Noda
Resources: Abstract
Topics: Gastrointestinal Cancers, Pancreatic Cancer

https://oncologypro.esmo.org/Meeting-Resour...-the-Middle-East-Case-for-sub-specialization

Pancreaticoduodenectomy or Whipple procedure has been increasingly performed for both benign and malignant lesions in the peri-ampullary region. It is a complex high-risk surgical procedure in terms of morbidity.

Date: 28 Jun 2017
Presenter: Mohamad Rachad Wehbe
Resources: Abstract
Topics: Gastrointestinal Cancers, Pancreatic Cancer

https://oncologypro.esmo.org/Meeting-Resour...n-the-Middle-East-A-single-center-experience

Pancreaticoduodenectomy is one of the most challenging yet rewarding surgical procedures. It has been acknowledged as the cure for several pathologies. Tumor resection through a pancreaticoduodenectomy...

Date: 28 Jun 2017
Presenter: Hussein Nassar
Resources: Abstract
Topics: Gastrointestinal Cancers, Pancreatic Cancer

https://oncologypro.esmo.org/Meeting-Resour...f-recurrence-and-long-term-clinical-outcomes

Most cases of esophageal squamous cell carcinoma (ESCC) recurred and eventually succumbed to the disease despite radical treatment. Immune checkpoint inhibitor showed early promise in metastatic disease...

Date: 28 Jun 2017
Presenter: AWI Lo
Resources: Abstract
Topics: Gastrointestinal Cancers, Oesophageal Cancer

https://oncologypro.esmo.org/Meeting-Resour...s-choice-of-surgical-treatment-of-insulinoma

Insulinoma is rare tumor which occurs in the islets of Langerhans and produced an excess of the hormone insulin, which is caused the development of a fasting hypoglycemic syndrome.

Date: 28 Jun 2017
Presenter: Mirjalol Djuraev
Resources: Abstract
Topics: Gastrointestinal Cancers, Pathology/Molecular Biology

https://oncologypro.esmo.org/Meeting-Resour...ith-mass-spectrometric-quantitation-of-TUBB3

No predictive biomarker for chemotherapy has been validated for clinical use. A relationship between resistance to taxanes and expression of class III β-tubulin (TUBB3) protein has been suggested by...

Date: 28 Jun 2017
Presenter: Daniel Catenacci
Resources: Abstract
Topics: Gastrointestinal Cancers, Gastric Cancer

https://oncologypro.esmo.org/Meeting-Resour...l-treatment-of-pancreatic-tumors-in-children

Background: Pancreatic tumors in children are uncommon. The knowledge of their presentation accrues principally through institutional case series. The very limited experience, together with the broad...

Date: 28 Jun 2017
Presenter: Olena Kolesnik
Resources: Abstract
Topics: Gastrointestinal Cancers, Pancreatic Cancer

https://oncologypro.esmo.org/Meeting-Resour...alysis-of-3523-patients-in-the-SEER-database

The aim of this study is to investigate trends in incidence and survivals for gastric neuroendocrine neoplasms (g-NENs).

Date: 28 Jun 2017
Presenter: Long-Long Cao
Resources: Abstract
Topics: Gastrointestinal Cancers, Gastric Cancer